HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,280,000 | – | 378,576 | – | 3.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 762,929 | $14,702,000 | 19.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $10,063,000 | 2.27% |
Capital International, Inc./CA/ | 4,191,161 | $79,297,000 | 0.89% |
GENERAL ATLANTIC, L.P. | 4,000,000 | $75,680,000 | 0.69% |
Capital International Sarl | 659,133 | $12,471,000 | 0.62% |
E Fund Management (Hong Kong) Co., Ltd. | 50,214 | $859,000 | 0.54% |
Bellevue Group AG | 1,750,690 | $33,123,000 | 0.38% |
AIA Group Ltd | 356,640 | $6,748,000 | 0.29% |
M&G INVESTMENT MANAGEMENT LTD | 5,704,897 | $108,393,000 | 0.21% |
Sands Capital Management | 4,189,421 | $79,264,000 | 0.18% |